Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Mark D. Bartholomä"'
Autor:
Sebastian Martin, Moritz-Valentin Schreck, Tobias Stemler, Stephan Maus, Florian Rosar, Caroline Burgard, Andrea Schaefer-Schuler, Samer Ezziddin, Mark D. Bartholomä
Publikováno v:
EJNMMI Radiopharmacy and Chemistry, Vol 9, Iss 1, Pp 1-23 (2024)
Abstract Background The NOTI chelating scaffold can readily be derivatized for bioconjugation without impacting its metal complexation/radiolabeling properties making it an attractive building block for the development of multimeric/-valent radiophar
Externí odkaz:
https://doaj.org/article/690f414b42e7461998ffb597601d58e9
Publikováno v:
EJNMMI Radiopharmacy and Chemistry, Vol 3, Iss 1, Pp 1-11 (2018)
Abstract Background We recently developed a chelating platform based on the macrocycle 1,4,7-triazacyclononane with up to three, five-membered azaheterocyclic arms for the development of 68Ga- and 64Cu-based radiopharmaceuticals. Here, a 68Ga-labelle
Externí odkaz:
https://doaj.org/article/ce6206cb9519407c8c4754d94f521e9a
Autor:
Sebastian, Martin, Roswitha, Tönnesmann, Ina, Hierlmeier, Stephan, Maus, Florian, Rosar, Juri, Ruf, Jason P, Holland, Samer, Ezziddin, Mark D, Bartholomä
Publikováno v:
Journal of medicinal chemistry. 64(8)
In recent years, radiolabeled tracers targeting prostate-specific membrane antigen (PSMA) have had a tremendous impact on prostate cancer management. Here, we report on the formation of radioactive impurities formed during the clinical production of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a8145c93e7803f48d0510dc93dc87606
https://pubmed.ncbi.nlm.nih.gov/33826320
https://pubmed.ncbi.nlm.nih.gov/33826320